~~<i id='1A96175BFF'><strike id='1A96175BFF'><tt id='1A96175BFF'><pre id='1A96175BFF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

fashion

author：fashion 2025-09-30 23:05:52 - browse：472

WASHINGTON — Congress is considering a must-pass pandemic preparedness bill that presents a good opportunity to fix the nation’s current drug shortages problem, which both parties want to do. But most indications are that lawmakers will let that opportunity pass them by.

Although not new, drug shortages are now a crisis, with an increasing number of reports about cancer doctors having to ration chemotherapies and other drugs.

Politicians have been well aware of the problem for years. At the request of a large bipartisan group of lawmakers, a task force chaired by the Food and Drug Administration in 2019 reported on the root causes of drug shortages.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： PBM reform efforts get punted in Congress

knowledge

Wikipedia

leisure time

knowledge

hotspot

Wikipedia

AdobeHospitals,pharmacies,andotherhealthcareprovidersaregettingstuckinaninsuranceprocessinglogjamaft

WSS

There’s no way to know how good AI health technologies are

Medicare inequities exacerbate Puerto Rico’s health disparities

How should state employee insurance handle Wegovy?

A solution to the after

European regulators consider appeal over Amylyx ALS drug

Life sciences deals on track to hit lowest point since 2017

entertainment

fashion

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Nick Jonas talks about managing diabetes along with his career

Bright Health sells Medicare Advantage business to Molina

Alabama frozen embryo ruling has major implications for IVF clinics

Peter Hotez and the public health issue of online harassment

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Dobbs anniversary: the lost opportunity of abortion as health care

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Sports medicine is finally prioritizing gender equality

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Wikipedia

European regulators consider appeal over Amylyx ALS drug

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

With competition flaring, obesity drug hits goal in liver disease study

Why palliative psychiatry is worth discussing

leisure time

knowledge

hotspot

Wikipedia